Advanced Biomed Statistics
Total Valuation
Advanced Biomed has a market cap or net worth of $39.17 million. The enterprise value is $38.42 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
Advanced Biomed has 21.64 million shares outstanding. The number of shares has increased by 0.11% in one year.
Current Share Class | 21.64M |
Shares Outstanding | 21.64M |
Shares Change (YoY) | +0.11% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 82.12% |
Owned by Institutions (%) | n/a |
Float | 3.87M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 58.48 |
P/TBV Ratio | 68.90 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 3.09.
Current Ratio | 0.82 |
Quick Ratio | 0.76 |
Debt / Equity | 3.09 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -744.99% and return on invested capital (ROIC) is -109.23%.
Return on Equity (ROE) | -744.99% |
Return on Assets (ROA) | -33.61% |
Return on Invested Capital (ROIC) | -109.23% |
Return on Capital Employed (ROCE) | -369.55% |
Revenue Per Employee | n/a |
Profits Per Employee | -$75,978 |
Employee Count | 40 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 30.76 |
Average Volume (20 Days) | 72,962 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.50M |
Pretax Income | -4.75M |
Net Income | -3.04M |
EBITDA | -2.19M |
EBIT | -2.50M |
Earnings Per Share (EPS) | -$0.15 |
Full Income Statement Balance Sheet
The company has $2.66 million in cash and $1.91 million in debt, giving a net cash position of $747,157 or $0.03 per share.
Cash & Cash Equivalents | 2.66M |
Total Debt | 1.91M |
Net Cash | 747,157 |
Net Cash Per Share | $0.03 |
Equity (Book Value) | 619,032 |
Book Value Per Share | 0.03 |
Working Capital | -689,903 |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$2.41 million and capital expenditures -$35,843, giving a free cash flow of -$2.45 million.
Operating Cash Flow | -2.41M |
Capital Expenditures | -35,843 |
Free Cash Flow | -2.45M |
FCF Per Share | -$0.11 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |